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Abstract
Objective:  To  investigate  the  association  of  Arg16Gly  and  Gln27Glu  polymorphisms  of  2-
adrenergic  receptor  gene  (ADRB2)  with  the  occurrence  of  asthma  and  overweight  and  the  gene’s
inﬂuence  on  anthropometric,  clinic,  biochemical  and  physical  ﬁtness  variables  in  children  and
adolescents.
Methods: Subjects  were  evaluated  for  allelic  frequencies  of  the  2-adrenergic  receptor  gene,
height, weight,  body  mass  index  (BMI),  BMI  Z-score,  waist  circumference  (WC),  pubertal  stage,
resting heart  rate  (HRres),  blood  pressure  (BP),  total  cholesterol  (TC),  glucose,  insulin,  high
density lipoprotein  (HDL-C),  low  density  lipoprotein  (LDL-C),  triglyceride  (TG),  Homeostasis
Metabolic  Assessment  (HOMA2-IR),  Quantitative  Insulin  Sensitivity  Check  Index  (QUICKI)  and
maximal oxygen  uptake  (VO2max).  The  participants  were  divided  in  four  groups:  overweight  asth-
matic (n=39),  overweight  non-asthmatic  (n=115),  normal  weight  asthmatic  (n=12),  and  normal
weight non-asthmatic  (n=40).
Results:  Regarding  the  Gln27Glu  polymorphism,  higher  total  cholesterol  was  observed  in  usual
genotype individuals  than  in  genetic  variant  carriers  (p=0.04).  No  evidence  was  found  that  the
evaluated  polymorphisms  are  inﬂuencing  the  physical  ﬁtness.  The  Arg16  allele  was  found  more
frequently  among  the  normal  weight  asthmatic  group  when  compared  to  the  normal  weight  non-
asthmatic group  (p=0.02),  and  the  Glu27  allele  was  more  frequently  found  in  the  overweight
asthmatics  group  when  compared  to  the  normal  weight  non-asthmatic  group  (p=0.03).rg16  allele  with  the  occurrence  of  asthma  and  of  the  Glu27Conclusions:  The  association  of  A
allele with  overweight  asthmatic  adolescents  evidenced  the  contribution  of  the  2-adrenergic
receptor gene  to  the  development  of  obesity  and  asthma.
© 2015  Sociedade  de  Pediatria  de  Sa˜o  Paulo.  Published  by  Elsevier  Editora  Ltda.  This  is  an  open
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Associac¸ão  do  gene  ADRB2  com  sobrepeso  e  asma  em  crianc¸as e  adolescentes  e  sua
relac¸ão  com  a  aptidão  física
Resumo
Objetivo:  Investigar  a  associac¸ão  dos  polimorﬁsmos  Arg16Gly  e  Gln27Glu  do  gene  receptor
2-adrenérgico  (ADRB2)  com  a  ocorrência  de  asma  e  sobrepeso,  bem  como  a  inﬂuência  do
gene sobre  variáveis  antropométricas,  clínicas,  bioquímicas  e  de  aptidão  física  em  crianc¸as  e
adolescentes.
Métodos: Os  indivíduos  foram  avaliados  quanto  à  frequência  alélica  do  gene  ADRB2,  altura,
peso, índice  de  massa  corporal,  IMC-escore  Z,  circunferência  abdominal,  estágio  puberal,  fre-
quência cardíaca  de  repouso,  pressão  sanguínea,  colesterol  total,  glicose,  insulina,  lipoproteína
de alta  densidade,  lipoproteína  de  baixa  densidade,  triglicerídeos,  Homeostasis  Metabolic
Assessment  (HOMA2-IR),  Quantitative  Insulin  Sensitivity  Check  Index  (QUICKI)  e  consumo  máx-
imo de  oxigênio  (VO2max).  Os  participantes  foram  divididos  em  quatro  grupos:  sobrepeso
asmático  (n=39),  sobrepeso  não  asmático  (n=115),  peso  normal  asmático  (n=12)  e  peso  normal
não asmático  (n=40).
Resultados:  Com  relac¸ão  ao  polimorﬁsmo  Gln27Glu,  foi  observado  maior  valor  de  colesterol
total nos  indivíduos  do  genótipo  usual  do  que  naqueles  que  carregam  a  variante  (p=0,04).  Não
foi encontrada  evidência  de  que  os  polimorﬁsmos  avaliados  inﬂuenciem  a  aptidão  física.  O
alelo Arg16  foi  encontrado  em  maior  frequência  no  grupo  de  peso  normal  asmático,  comparado
ao grupo  de  peso  normal  não  asmático  (p=0,02),  e  o  alelo  Glu27  foi  mais  frequentemente
encontrado  no  grupo  de  sobrepeso  asmático,  quando  comparado  ao  grupo  de  peso  normal  não
asmático (p=0,03).
Conclusões:  A  associac¸ão  do  alelo  Arg16  com  a  ocorrência  de  asma  e  a  associac¸ão  do  alelo
Glu27 a  adolescentes  com  sobrepeso  asmáticos  evidenciam  a  contribuic¸ão  do  gene  ADBR2  para
o desenvolvimento  da  obesidade  e  asma.
© 2015  Sociedade  de  Pediatria  de  Sa˜o  Paulo.  Publicado  por  Elsevier  Editora  Ltda.  Este  é  um  artigo
Open Access  sob  a  licença  CC  BY  (https://creativecommons.org/licenses/by/4.0/deed.pt).
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verweight  and  asthma  are  chronic  diseases  that  reach
larming  prevalence  and  morbidity.1 Excess  of  weight  has
een  associated  with  the  emergence  of  respiratory  prob-
ems  such  as  asthma.2 Although  the  complex  interaction
etween  environmental  exposure  and  genetic  predisposi-
ion  to  overweight  and  the  development  of  asthma  is  not
ell  deﬁned,  studies  have  shown  that  genetic  factors  may
nﬂuence  the  susceptibility  to  develop  obesity,3 and  the
ssociation  between  genetic  polymorphisms  and  asthma  has
een  reported.4
Beta2-adrenergic  receptors  (ADRB2)  are  found  in  several
egions  of  the  body,  including  fat  cells,  blood  vessels,  heart
nd  airways.5 These  receptors  play  an  important  role  in  the
enesis  of  obesity  and  energy  balance  regulation.  They  are
esponsible  for  the  stimulation  of  the  lipolytic  activity  in  adi-
ose  tissue6 and  for  the  control  of  bronchial  smooth  muscle,7
hrough  relaxation  and  bronchodilation  of  airway  smooth
uscle.8
The  Arg16Gly  (rs1042713)  and  Gln27Glu  (rs1042714)  poly-
orphisms  in  the  ADRB2  gene  seem  to  be  related  to
he  development  of  overweight,  hypertension,  metabolic
yndrome,9,10 and  asthma  exacerbations.11,12 They  are  asso-
iated  with  changes  in  the  sympathetic  nervous  system
ctivity  and  may  alter  lipolysis,9 metabolic  and  cardiovas-
ular  regulation,13 as  well  as  decrease  lung  function  and
ronchodilator  response  to  therapy  with  2-agonists.14
A
(
BIn  children  and  adolescents,  the  association  between
rg16Gly  and  Gln27Glu  polymorphisms  with  obesity  or
sthma  was  investigated  separately,  with  controversial
esults15,16;  however,  no  study  has  evaluated  the  frequencies
f  these  polymorphisms  in  children  and  adolescents  consid-
ring  obesity  and  asthma  together.  Association  between
ln27Glu  polymorphism  and  physical  ﬁtness  has  been
bserved  only  in  adults.17
The  aim  of  the  present  study  was  to  investigate  the
ssociation  of  the  alleles  of  the  Arg16Gly  and  Gln27Glu  poly-
orphisms  of  ADRB2  gene  with  the  occurrence  of  asthma
nd  overweight  in  children  and  adolescents  and  to  examine
hether  those  polymorphisms  inﬂuence  on  anthropometric,
linic,  lipid  proﬁle  and  physical  ﬁtness  variables.
ethod
he  sample  consisted  of  206  children  and  adolescents  of
oth  sexes,  10  to  16  years  old  from  southern  Brazil,  divided
nto  four  groups:  overweight  asthmatics  (n=39),  overweight
on-asthmatics  (n=115),  normal  weight  asthmatic  (n=12)
nd  normal  weight  non-asthmatic  (control)  (n=40).  The  par-
icipants  were  volunteers  from  the  Pediatric  Endocrinology
mbulatory  and  from  public  schools  of  Curitiba,  Paraná
Brazil).
The  inclusion  criteria  for  overweight  participants  were:
MI  above  the  85th  percentile  of  the  World  Health
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Table  1  Allelic  frequencies  of  the  Arg16Gly  and  Gln27Glu  polymorphism  of  ADRB2  gene  among  the  groups.
Alleles  Overweight/
asthmatic  n  (%)
Overweight/
non-asthmatic  n  (%)
Normal  weight/
asthmatic  n  (%)
Normal  weight/
non-asthmatic  n  (%)
Arg16Gly
Arg  16  26  (37%)  60  (39%)  12  (60%)a 22  (31%)
Gly 16  44  (63%)  92  (61%)  8  (40%)  48  (69%)
Total 70  (100%)  152  (100%)  20  (100%)  70  (100%)
Gln27Glu
Gln 27  22  (50%)  98  (66%)  13  (65%)  41  (71%)
Glu 27  22  (50%)b 50  (34%)  7  (35%)  17  (29%)
Total 44  (100%)  148  (100%)  20  (100%)  58  (100%)
a Signiﬁcantly higher frequency compared to normal weight non-asthmatic group (p=0.02).
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Organization  (WHO)18 and,  for  asthmatic  participants,  being
diagnosed  with  asthma  by  medical  evaluation  and  clinical
history  as  recommended  by  the  Brazilian  Thoracic  Society
(Sociedade  Brasileira  de  Pneumologia  e  Tisiologia  -SBPT).19
In  this  study,  participants  were  not  classiﬁed  by  the  sever-
ity  of  asthma.  Exclusion  criteria  were:  presence  of  diabetes
and  the  use  of  anorectic  drugs  or  others  that  may  interfere
with  weight  control,  insulin  levels,  blood  pressure,  glucose
or  lipid  metabolism.
Participants  and  their  guardians  signed  the  Informed
Consent  Form,  according  to  the  protocol  approved  by  the
Institutional  Review  Board  of  the  Federal  University  of
Paraná  (CEP/HC2460.067/2011-03).
Height  was  measured  in  centimeters  (cm)  using  a  sta-
diometer  ﬁxed  to  the  wall  (accurate  to  0.1  cm),  and  weight
was  measured  in  kilograms  (kg),  using  a  digital  scale  (max-
imum  capacity  of  150kg  and  a  resolution  of  100g).  BMI,
expressed  in  kg/m2,  was  calculated  and  classiﬁed  accord-
ing  to  the  cutoff  points  for  age  and  sex  as  proposed  by  the
World  Health  Organization.18 The  waist  circumference  (WC)
was  measured  in  centimeters  with  a  ﬂexible  and  inextensi-
ble  anthropometric  tape  (accuracy  0.1cm).  Systolic  (SBP)
and  diastolic  (DBP)  blood  pressures  were  measured  after
10  minutes  of  rest,  with  the  individual  seated  and  with  the
right  arm  supported  at  heart  level.
Blood  samples  were  collected  in  the  clinical  labora-
tory  in  the  morning,  after  12h  of  fasting,  to  perform  a
complete  blood  count,  measurement  of  glucose,  insulin,
total  cholesterol  (TC),  high-density  lipoprotein  (HDL-C),
low-density  lipoprotein  cholesterol  (LDL-C),  and  triglyceride
(TG).  The  concentrations  of  TC,  HDL-C,  TG  (mg/dL)  and
glucose  were  analyzed  by  automated  enzymatic  colorimet-
ric  method  (CHOD-PAP)  (Lab  Merck,  Darmstadt,  Germany;
Laboratory  Roche,  Indianapolis,  IN,  USA).
Fasting  insulin  concentration  was  measured  by  chemi-
luminescence  immunoassay  technique  immunometric
U/mL.  The  HOMA  Calculator  v2.2  software  was  used
to  calculate  the  insulin  resistance,  and  the  Quantitative
Insulin  sensitivity  Check  Index  (QUICKI),  described  by  Katz
et  al.,20 was  used  to  evaluate  insulin  sensitivity.The  aerobic  ﬁtness  analysis  was  made  on  the  treadmill,
and  ventilatory  responses  were  measured  using  a  cali-
brated  breath-by-breath  monitoring  system  (Parvo  Medics,
True  Max  2400,  Utah,  USA),  which  provided  information  on
c
n
nmatic group (p=0.03).
xygen  uptake  (VO2),  carbon  dioxide  production  (VCO2),  pul-
onary  ventilation  (LV),  and  ratio  of  respiratory  exchange
RER=VCO2/VO2).  These  variables  were  monitored  every
5  s.  Heart  rate  was  monitored  using  a  heart  rate  monitor
Polar  --  model  A1,  Finland).  To  ensure  that  participants  had
chieved  peak  oxygen  uptake  (VO2max),  at  least  2  of  the  fol-
owing  criteria  were  observed:  (a)  exhaustion  or  inability
o  maintain  the  required  speed;  (b)  RER>1.0;  (c)  maximum
eart  rate  (HR)>190  bpm.
Blood  samples  (n=100)  were  submitted  to  leukocyte  DNA
xtraction  by  a  salting-out  method21 and  diluted  to  the
oncentration  of  20  ng/L.  Variants  were  genotyped  by  Taq-
an  SNP  Genotyping  Kit  (Applied  Biosystems)  on  the  device
ealplex  2  Mastercycler  (Eppendorf).  The  reaction  mix  con-
ained  5.0L  of  TaqMan  Universal  PCR  Master  Mix,  0.5L of
peciﬁed  TaqMan  SNP  Genotyping  Kit,  2.5L  of  ultra-pure
ater  and  2L  of  DNA  (20ng/L).  Four  samples  of  each
enotype  were  sequenced  for  method  validation.
To  verify  the  normality  distribution  of  data,
he  Kolmogorov--Smirnov  test  was  used.  T  test  and
ann--Whitney  test  were  used  for  comparisons  of  means  for
ariables  with  and  without  normal  distribution,  respectively.
he  allelic  frequencies  between  groups  were  evaluated
y  2 tests  using  Clump  software.22 Signiﬁcance  was  set
t  a p-value  <0.05,  and  the  analysis  was  performed  using
tatistica  for  Windows  v.10  (StatSoft  Inc.,  Tulsa,  EUA)
esults
he  allele  frequencies  of  the  Arg16Gly  and  Gln27Glu  poly-
orphism  of  ADRB2  gene  in  each  of  the  groups  are  shown  in
able  1. The  Arg16  allele  was  found  with  a  higher  frequency
n  the  normal  weight  asthmatic  group  when  compared  to
he  normal  weight  non-asthmatic  group  (p=0.02).  For  the
ln27Glu  polymorphism,  a  signiﬁcantly  higher  frequency  of
he  Glu27  allele  was  observed  in  the  overweight  asthmatic
roup  when  compared  to  the  normal  weight  non-asthmatic
roup  (p=0.03),  and  there  was  a  tendency  to  signiﬁcantly
igher  frequency  in  the  overweight  asthmatic  group  when
ompared  to  the  overweight  non-asthmatic  group  (p=0.05).
The  evaluated  groups  (overweight  asthmatic,  overweight
on-asthmatic,  normal  weight  asthmatic  and  normal  weight
on-asthmatic)  were  pooled  to  verify  the  possible  effect  of
384  Leite  N  et  al.
Table  2  Means  ±  SD  of  anthropometric,  cardiorespiratory  ﬁtness,  blood  pressure,  biochemical  and  metabolic  proﬁle  variables
and comparisons  between  mutation  carriers  (Arg  Gly/Gly  Gly)  and  usual  genotype  carriers  (Arg  Arg)  according  to  the  Arg16Gly
polymorphism  site  genotypes.
Variables  Arg  Arg  Arg  Gly/Gly  Gly  t  or  Z  p-value
Age  13.35  ±  1.61  13.00  ±  1.83  0.95  0.34
Weight (kg)  70.76  ±  19.51  68.60  ±  19.48  0.54  0.58
Height (cm)a 161.03  ±  9.89  147.43  ±  42.29  1.74  0.08
BMI (kg/m2)  26.91  ±  5.89  26.86  ±  6.65  0.03  0.97
BMI Z-scorea 1.96  ±  1.47  2.00  ±  1.51  0.14  0.88
WC (cm)  91.11  ±  17.19  89.94  ±  16.93  0.33  0.73
HRres (bpm) 79.88  ±  9.18  80.15  ±  12.17  −0.10  0.91
VO2max (mL/kg/min) 36.46  ±  7.81 35.16  ±  7.91 0.68 0.49
SBP (mmHg)a 108.34  ±  13.08 104.20  ±  12.49 1.87 0.06
DBP (mmHg)a 70.68  ±  11.51  68.34  ±  10.27  1.09  0.27
TC (mg/dL)a 167.32  ±  36.39  161.79  ±  29.31  0.37  0.70
HDL-C (mg/dL)a 47.55  ±  9.73  49.95  ±  12.43  −0.51  0.60
LDL-C (mg/dL)a 95.34  ±  31.42  88.69  ±  26.20  0.70  0.48
TG (mg/dL)a 115.20  ±  78.23  105.34  ±  61.36  0.11  0.91
Glucose (mg/dL) 88.80  ±  7.10  88.25  ±  7.96  0.31  0.74
Insulin (mU/mL)a 12.29  ±  9.20 12.92  ±  9.97  −0.37  0.70
HOMA2-IRa 1.57  ±  1.16  1.63  ±  1.21  −0.39  0.69
HOMA2-IRa 1.57  ±  1.16 1.63  ±  1.21  −0.39  0.69
QUICKIa 0.35  ±  0.04  0.35  ±  0.04  0.39  0.69
BMI, body mass index; WC, waist circumference; HRres; resting heart rate; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC,
total cholesterol; HDL-C, high density lipoprotein; LDL-C, low density lipoprotein; TG, triglyceride; HOMA2-IR, Homeostasis Metabolic
Assessment; QUICKI, Quantitative Insulin Sensitivity Check Index; VO2max, maximal oxygen uptake.
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ta Variables without normal distribution.
he  polymorphisms  on  anthropometric,  clinic,  lipid  proﬁle
nd  physical  ﬁtness  variables.  When  separated,  according
o  the  Arg16Gly  site  genotypes,  into  mutation  carriers  (Arg
ly/Gly  Gly)  and  usual  genotype  carriers  (Arg  Arg),  the  com-
arisons  of  the  means  of  anthropometric,  cardiorespiratory
tness,  blood  pressure,  biochemical  and  metabolic  proﬁle
ariables  were  not  signiﬁcantly  different  (Table  2).
When  separated  into  mutation  carriers  (Gln  Glu/Glu
lu)  and  usual  genotype  carriers  (Gln  Gln),  according  to
he  Gln27Glu  polymorphism  site  genotypes,  the  comparison
f  the  mean  and  SD  of  anthropometric,  cardiorespiratory
tness  blood  pressure,  biochemical  and  metabolic  proﬁle
ariables  showed  no  signiﬁcant  differences,  except  for  a sig-
iﬁcantly  higher  mean  of  TC  observed  in  the  usual  genotype
arrier  group  (Gln  Gln)  (Table  3).
iscussion
he  prevalence  of  overweight  in  the  Brazilian  population
ged  between  10  and  19  is  20.5%,23 whereas  10.3%  of
hildren  and  13.8%  of  adolescents  have  asthma.24 Genetic
actors  have  been  demonstrated  to  contribute  to  the  devel-
pment  of  obesity  and  asthma  during  childhood,  but  the
oles  of  speciﬁc  genes  and  their  interaction  are  still  largely
nknown.3,4,15 The  Arg16Gly  and  Gln27Glu  polymorphisms  in
he  ADRB2  gene  have  been  related  to  the  development  of
verweight9 and  asthma  exacerbations.11,12
The  previously  described  population  frequencies  for  the
ly16  allele  and  for  the  Gln27  alleles  are  60.4%  and  52.7%,
espectively.11 In  obese  children  and  adolescents  similar
v
n
orequencies  were  found:  59%  for  Gly16  allele  and  62%  for
ln27  allele.25 In  a  recent  study,  the  allele  frequency  for
ly16  in  asthmatic  children  and  adolescents  was  55%,  and
3%  for  Gln27.26
The  higher  frequency  of  the  Arg16  allele  of  Arg16Gly
olymorphism  observed  in  the  present  study  in  the  asth-
atic  group,  when  compared  to  the  control  group,  suggests
hat  the  presence  of  this  allele  may  be  associated  with  the
ccurrence  of  asthma.  A  tendency  to  a  signiﬁcantly  higher
requency  of  the  Gly16  allele  was  observed  in  the  overweight
sthmatic  group  when  compared  to  the  normal  weight  asth-
atic  group  (p=0.06),  suggesting  that  the  presence  of  the
ly16  allele  may  be  related  to  overweight  in  asthmatic  indi-
iduals.  Ellsworth  et  al.15 found  an  association  between
rg16Gly  polymorphism  and  obesity  in  male  participants:
hose  with  Gly  Gly  genotype  showed  an  increase  in  BMI  dur-
ng  infancy  until  young  adulthood.  Different  results  were
ound  in  adolescent  girls,  showing  that  carriers  of  the  Gly  Gly
enotype  have  a  lower  probability  of  obesity  than  those  with
rg  Gly  or  Arg  Arg  genotypes  (p=0.006),  and  girls  with  Gly
ly  genotype  have  lower  BMI  compared  to  those  with  Arg  Arg
enotype  (p=0.049),  but  higher  BMI  compared  to  the  Arg  Gly
p=0.062)  genotype.16 In  another  study,  female  participants
ho  were  carriers  of  the  Arg  Arg  genotype  showed  higher
MI  when  compared  to  those  with  the  Gly  Gly  genotype.27
n  the  present  study,  genders  were  analyzed  together  due
o  the  small  sample  size.  When  classiﬁed  by  usual  genotype
ersus  mutation  carriers  of  the  Arg16Gly  polymorphism  site,
o  differences  were  found  for  anthropometric  variables.
For  the  Gln27Glu  polymorphism  site,  a  higher  frequency
f  the  Glu27  allele  was  observed  in  the  overweight  asthmatic
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Table  3  Means  ±  SD  of  anthropometric,  cardiorespiratory  ﬁtness,  blood  pressure,  biochemical  and  metabolic  proﬁle  variables
and comparisons  between  mutation  carriers  (Gln  Glu/Glu  Glu)  and  usual  genotype  carriers  (Gln  Gln)  according  to  the  Gln27Glu
polymorphism  site  genotypes.
Variable  Gln  Gln  Gln  Glu/Glu  Glu  t  or  Z  p-value
Age  13.16  ±  2.02  13.29  ±  1.64  −0.42  0.67
Weight (kg)  64.81  ±  19.37  71.63  ±  22.31  −1.91  0.05
Height (cm)b 151.74  ±  33.15  148.43  ±  45.50  1.33  0.18
BMI (kg/m2)  25.50  ±  6.38  27.10  ±  7.48  −1.34  0.18
BMI Z-scoreb 1.69  ±  1.57  1.98  ±  1.64  0.86  0.38
WC (cm)  86.96  ±  17.44  92.38  ±  19.12  −1.76  0.08
HRres (bpm) 77.76  ±  10.38  81.32  ±  10.93  −1.73  0.08
VO2max (mL/kg/min) 35.86  ±  7.22 37.34  ±  6.55 −1.03 0.30
SBP (mmHg)b 104.81  ±  13.06 105.02  ±  13.99 0.12 0.90
DBP (mmHg)b 70.62  ±  10.59  66.98  ±  10.76  −1.45  0.14
TC (mg/dL)a,b 169.23  ±  34.93  158.48  ±  31.51  −1.99  0.04a
HDL-C  (mg/dL)b 50.63  ±  11.99  49.79  ±  12.58  −0.10  0.91
LDL-C (mg/dL)b 95.39  ±  33.67  88.20  ±  30.95  −1.40  0.16
TG (mg/dL)b 108.67  ±  71.94  102.53  ±  60.71  0.03  0.97
Glucose (mg/dL) 87.72  ±  7.76  87.65  ±  6.76  0.05  0.95
Insulin (mU/mL)b 11.85  ±  10.72 12.46  ±  7.94  1.08  0.27
HOMA2-IRb 1.50  ±  1.29  1.58  ±  0.98  1.11  0.26
QUICKIb 0.36  ±  0.05 0.34  ±  0.04  −1.03  0.30
BMI, body mass index; WC, waist circumference; HRres, resting heart rate; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC,
total cholesterol; HDL-C, high density lipoprotein; LDL-C, low density lipoprotein; TG, triglyceride; HOMA2-IR, Homeostasis Metabolic
Assessment; QUICKI, Quantitative Insulin Sensitivity Check Index; VO2max, maximal oxygen uptake.
a Statistically signiﬁcant difference.
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group  when  compared  to  the  control  group  (p=0.03),  and
there  was  a  tendency  toward  signiﬁcance  when  compared
to  the  non-asthmatic  overweight  group  (p=0.05),  suggesting
that  the  Glu27  allele  may  be  involved  in  the  development
of  asthma  in  overweight  individuals.  Large  et  al.9 found
the  Glu27  allele  associated  with  obesity,  and  Ochoa  et  al.28
found  no  association  between  Gln27Glu  polymorphism  and
obesity  in  boys,  but  in  female  carriers  of  the  Glu27  allele
they  found  a  higher  risk  of  obesity.  Research  has  shown  that
African  American  girls  who  are  carriers  of  the  Glu/Glu  geno-
type  have  higher  mean  WC  than  girls  without  the  allele,  an
association  not  found  among  boys.29 In  the  present  work,
when  separated  by  usual  genotype  and  mutation  carriers  for
the  Gln27Glu  site,  no  differences  were  found  for  anthropo-
metric  variables.
There  is  evidence  that  adrenoceptor  genetic  variants
have  a  role  in  the  physiopathology  of  hypertension,  but  the
results  on  the  relationship  between  the  ADRB2  polymor-
phisms  are  still  discordant.10 A  study  from  Chou  et  al.16 found
an  association  of  the  Arg16Gly  polymorphism  with  hyper-
tension  in  obese  adolescents,  showing  that  carriers  of  the
Gly/Gly  genotype  have  a  lower  probability  of  hypertension
than  patients  with  Arg/Gly  or  Arg/Arg  genotypes  (p=0.005).
No  other  study  so  far  associated  ADRB2  polymorphisms  and
blood  pressure  in  children  and  adolescents.  In  the  present
study,  no  evidence  was  found  that  the  evaluated  polymor-
phisms  are  acting  on  the  blood  pressure  variables.Adrenergic  receptors  play  an  important  role  in  the  lipol-
ysis  regulation  and  energy  expenditure,  so  it  is  possible
that  polymorphisms  in  these  genes  contribute  to  the  emer-
gence  of  metabolic  changes.30 A  Brazilian  study  with  obese
F
Thildren  did  not  ﬁnd  differences  in  metabolic  and  biochemi-
al  variables  (glucose,  TC,  LDL-C,  HDL-C,  TG,  leptin,  insulin,
lucose  area  and  insulin,  and  HOMA-IR)  between  haplotypes
or  Arg16Gly  and  Gln27Glu  polymorphisms.13 In  the  present
ork,  when  separated  by  usual  genotype  versus  mutation
arriers  of  the  Arg16Gly  polymorphism  site,  no  differences
ere  found  for  metabolic  and  biochemical  variables.  As  for
he  Gln27Glu  polymorphism  site,  the  usual  group  showed
igher  mean  TC  value  when  compared  to  the  mutation  car-
ier  group.
The  association  of  the  Arg16  allele  with  the  occurrence
f  asthma  and  of  the  Glu27  allele  with  the  development  of
sthma  in  overweight  individuals  evidenced  the  contribution
o  the  development  of  obesity  and  asthma  during  childhood
nd  adolescence.  The  possible  association  between  studied
olymorphisms  and  gender  as  well  as  the  severity  of  the  dis-
ase  cannot  be  evaluated,  since  the  division  of  the  patients
nto  four  groups  reduced  the  number  of  each,  and  this  was
he  main  limitation  of  the  study.  Further  studies  with  larger
ample  sizes  may  allow  the  differentiation  of  groups  by  gen-
er,  as  well  as  the  implementation  of  more  robust  statistical
nalysis  regarding  the  roles  of  the  Arg16  and  Glu27  alleles
n  childhood  overweight/obesity  and  asthma.  The  evaluated
olymorphisms  seem  not  to  inﬂuence  on  the  physical  ﬁtness
n  childhood  and  adolescence.unding
his  study  did  not  receive  funding.
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